AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
Halozyme Therapeutics
HALO
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||
Cash flow from continuing operating activities | 9.73%-7.61M | -47.60%-8.43M | -171.71%-5.71M | -93.11%-2.1M | -126.40%-1.09M | -481K |
Net income from continuing operations | -0.83%-7.88M | -20.29%-7.81M | -148.51%-6.5M | -107.79%-2.61M | -28.76%-1.26M | ---977K |
Operating gains losses | 200.00%68K | ---68K | ---- | ---- | ---- | ---- |
Depreciation and amortization | 57.35%107K | 195.65%68K | 109.09%23K | 57.14%11K | 0.00%7K | --7K |
Other non cash items | 324.44%101K | ---45K | ---- | -64.29%20K | 12.00%56K | --50K |
Change In working capital | 67.28%-267K | -2,532.26%-816K | -117.13%-31K | 364.10%181K | -86.60%39K | --291K |
-Change in receivables | 335.79%448K | 60.42%-190K | -879.59%-480K | 20.97%-49K | -164.58%-62K | --96K |
-Change in inventory | 73.78%-269K | -20,620.00%-1.03M | -44.44%5K | 175.00%9K | -192.31%-12K | --13K |
-Change in prepaid assets | -456.10%-228K | -151.90%-41K | 276.19%79K | -91.67%21K | --252K | ---- |
-Change in payables and accrued expense | -148.12%-218K | 20.16%453K | 97.38%377K | 233.57%191K | -183.63%-143K | --171K |
-Change in other current liabilities | ---- | ---- | ---- | ---- | ---- | --0 |
-Change in other working capital | ---- | 0.00%-12K | -233.33%-12K | 125.00%9K | -63.64%4K | --11K |
Cash from discontinued investing activities | ||||||
Operating cash flow | 9.73%-7.61M | -47.60%-8.43M | -171.71%-5.71M | -93.11%-2.1M | -126.40%-1.09M | ---481K |
Investing cash flow | ||||||
Cash flow from continuing investing activities | 175.26%3.2M | -6,336.36%-4.25M | -83.33%-66K | -125.00%-36K | -1,500.00%-16K | -1K |
Net PPE purchase and sale | 77.84%-43K | -304.17%-194K | -33.33%-48K | -125.00%-36K | -1,500.00%-16K | ---1K |
Net investment purchase and sale | 179.92%3.24M | ---4.05M | --0 | --0 | ---- | ---- |
Net other investing changes | ---- | ---- | ---18K | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||
Investing cash flow | 175.26%3.2M | -6,336.36%-4.25M | -83.33%-66K | -125.00%-36K | -1,500.00%-16K | ---1K |
Financing cash flow | ||||||
Cash flow from continuing financing activities | 114.65%6.7M | -79.04%3.12M | 406.43%14.88M | 2.94M | 0 | 1.9M |
Net issuance payments of debt | --764K | --0 | --0 | --0 | --0 | --1.9M |
Net common stock issuance | 255.15%5.93M | -88.65%1.67M | --14.72M | --0 | --0 | ---- |
Proceeds from stock option exercised by employees | --0 | 805.63%1.45M | -94.53%160K | --2.93M | --0 | ---- |
Net other financing activities | ---- | ---- | ---- | --12K | ---- | ---- |
Cash from discontinued financing activities | ||||||
Financing cash flow | 114.65%6.7M | -79.04%3.12M | 406.43%14.88M | --2.94M | --0 | --1.9M |
Net cash flow | ||||||
Beginning cash position | -92.19%810K | 714.21%10.37M | 168.21%1.27M | -69.94%475K | 875.31%1.58M | --162K |
Current changes in cash | 123.83%2.28M | -205.10%-9.56M | 1,038.80%9.1M | 172.31%799K | -177.93%-1.11M | --1.42M |
End cash Position | 281.36%3.09M | -92.19%810K | 714.21%10.37M | 168.21%1.27M | -69.94%475K | --1.58M |
Free cash flow | 11.27%-7.66M | -49.74%-8.63M | -169.38%-5.76M | -93.57%-2.14M | -129.25%-1.11M | ---482K |
Currency Unit | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | -- | -- |